Clinical Trial Update: Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing daily versus intermittent regimen of ATT (anti-tuberculosis therapy) in patients with HIV and pulmonary tuberculosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Pulmonary Tuberculosis

Snippet

Sponsor: Tuberculosis Research Centre, India | Conditions: HIV Infection, Pulmonary TB | Phase 3 | Status: COMPLETED